Differences of Ab immunoreactivity gave us a measurement of higher levels of PAR-1 activation in epithelial cells from both the central and distal airways of COPD smokers, rather than in COPD ex-smokers. This evidence concerns the gene F2R and chronic obstructive pulmonary disease.